6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients

Name: 6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients
SKU: 25226
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 52 No. 2 Articles 2022 Tags: antipsychotic drugs, bipolar-disorder, Camilla Callegari, CRP, ERS, Franca Marino, inflammation, Marco Cosentino, Marco Ferrari, Marco Godio

Description

Description

Original Research

6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients

By Marco Ferrari, Marco Godio, Camilla Callegari, Marco Cosentino, Franca Marino

6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients

Description

Original Research

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Use of Lamotrigine for Bipolar Disorder in Pregnancy and Breastfeeding

Pharmacology of Valproate

Psychosocial Interventions for Bipolar Disorder: A Review of Literature and Introduction of the Systematic Treatment Enhancement Program

Title

6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients

Description

Original Research

Related products

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Use of Lamotrigine for Bipolar Disorder in Pregnancy and Breastfeeding

Pharmacology of Valproate

Psychosocial Interventions for Bipolar Disorder: A Review of Literature and Introduction of the Systematic Treatment Enhancement Program

Title